Clinical and direct immunofluorescence characteristics of cutaneous toxicity associated with enfortumab vedotin.

Saved in:
Bibliographic Details
Title: Clinical and direct immunofluorescence characteristics of cutaneous toxicity associated with enfortumab vedotin.
Authors: Penny CL; Duke University School of Medicine, Durham, NC, USA., Quow K; Department of Dermatology, Duke University Medical Center, Durham, NC, USA., Rundle CW; Department of Dermatology, Duke University Medical Center, Durham, NC, USA., Al-Rohil RN; Department of Dermatology, Duke University Medical Center, Durham, NC, USA.; Department of Pathology, Duke University Medical Center, Durham, NC, USA., Cardones AR; Department of Dermatology, Duke University Medical Center, Durham, NC, USA., Kheterpal MK; Department of Dermatology, Duke University Medical Center, Durham, NC, USA., Fresco AI; Department of Dermatology, Duke University Medical Center, Durham, NC, USA.
Source: The British journal of dermatology [Br J Dermatol] 2022 Jul; Vol. 187 (1), pp. 126-127. Date of Electronic Publication: 2022 Apr 19.
Publication Type: Case Reports; Letter
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2133
DOI:10.1111/bjd.21022